Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 33.2B | 38.5B | 34.5B | 36.7B |
Cost of revenue | 26.7B | 31.0B | 28.3B | 28.9B |
Gross profit | 6.6B | 7.4B | 6.2B | 7.8B |
Operating expense | ||||
Research & development | 1.6B | 969M | 1.7B | 1.5B |
Selling general and admin | 3.1B | 3.6B | 2.8B | 3.1B |
Other operating expenses | 70M | 47M | 72M | 140M |
Operating income | 2.2B | 3.2B | 2.1B | 3.7B |
Non operating interest income | ||||
Income | 180M | 188M | 165M | 175M |
Expense | 118M | 153M | 236M | 111M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 3.3B | 2.6B | 4.2B |
Tax provision | 691M | 704M | 926M | 1.1B |
Net income | 1.7B | 2.6B | 1.7B | 3.1B |
Basic EPS | 0.5 | — | 0.5 | 0.8 |
Diluted EPS | 0.5 | — | 0.5 | 0.8 |
Basic average shares | 3.4B | — | 3.6B | 3.6B |
Diluted average shares | 3.4B | — | 3.6B | 3.6B |
EBITDA | 4.6B | 5.3B | 4.5B | 5.9B |
Net income from continuing op. | 2.4B | 3.3B | 2.6B | 4.2B |
Minority interests | -53M | -119M | 14M | -46M |
Preferred stock dividends | 0 | 0 | 0 | 0 |